This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

The Health Economics of Prescribing in Invasive Fungal Disease

Prescribing information can be found at the bottom of the page.


Join us on 12 June 2024 to hear from Andy Bryan, Clinical Effectiveness Consultant discussing 'The Health Economics of Prescribing in Invasive Fungal Disease' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer.

Prescribing information can be found at the bottom of the page.


Join us on 12 June 2024 to hear from Andy Bryan, Clinical Effectiveness Consultant discussing 'The Health Economics of Prescribing in Invasive Fungal Disease' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer.

Event Date12 June 2024 12:30 BSTDuration1 Hr AudienceSpecialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 12:15 - 12:30Joining & Registration
12:30 - 12:45Introduction to The Health Economics of Prescribing in Invasive Fungal Disease Andy Bryan
12:45 - 12:55How the Choice of Antifungal might Impact the Healthcare Resources Used Andy Bryan
12:55 - 13:05Budget Impact: An Example Comparing CRESEMBA™ (isavuconazole) and VFEND® (voriconazole) Andy Bryan
13:05 - 13:15Drug Costs and the Benefits of Having An Oral option: CRESEMBA™ (isavuconazole) and Liposomal Amphotericin-B Compared Andy Bryan
13:15 - 13:30Questions & Answers Andy Bryan
13:30Meeting Close
Speakers
Event Speakers
Andy Bryan
Andy BryanClinical Effectiveness Consultant, Pfizer Ltd

Andy has over 20 years’ experience within Pfizer of helping NHS stakeholders consider prescribing decisions in the context of local and national healthcare priorities. 

Currently has a national Health Economics remit in support of the management of patients requiring COVID treatments, antibacterials or antifungals.

Came to Pfizer after a career in Project Management, Business Consulting and Lecturing. 

Andy has a BA (Hons) in Business Studies with an Accounting specialisation and a Master’s Degree in Business (MBA) focusing on Business Strategy. 

He is also co-author of published academic work in the area of antifungal Health Economics. 

Cresemba®(isavuconzole) 

Prescribing Information

Vfend®(voriconazole) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-CRB-GBR-2479. May 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​